BOGLE INVESTMENT MANAGEMENT L P /DE/ - AKEBIA THERAPEUTICS INC ownership

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 167 filers reported holding AKEBIA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of AKEBIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$262,000
-56.4%
19,300
-71.6%
0.04%
+2.3%
Q3 2018$601,000
-64.1%
68,076
-20.0%
0.04%
-62.3%
Q3 2017$1,674,000
+597.5%
85,131
+358.1%
0.11%
+570.6%
Q4 2015$240,000
-87.8%
18,585
-90.3%
0.02%
-88.4%
Q2 2015$1,969,000191,3730.15%
Other shareholders
AKEBIA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 4,652,561$3,340,0005.66%
Orchard Capital Management, LLC 1,762,731$1,265,0000.36%
Ikarian Capital, LLC 1,200,000$860,0000.11%
Ikarian Capital, LLC 800,000$575,0000.08%
XTX Topco Ltd 102,392$74,0000.03%
Nantahala Capital Management 965,800$693,0000.03%
Worth Venture Partners, LLC 63,500$46,0000.02%
Ardent Capital Management, Inc. 43,429$31,0000.02%
Virtus ETF Advisers LLC 65,149$47,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 513,292$368,0000.02%
View complete list of AKEBIA THERAPEUTICS INC shareholders